Yahoo · Oct 29, 2026
Molina: 3 Key Takeaways for Long-Term Investors
Medicaid margins may have bottomed as state rate increases align with care costs, setting up a multiyear recovery cycle.
NYSE · MOH
Molina Healthcare, Inc.
Healthcare · Medical - Healthcare Plans
$207.85
Up+$18.57 (+8.93%)
Updated Nov 4, 2026, 11:36 PM
SID Score
6.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 9.04B
- P/E ratio
- 10.13
- Dividend yield
- 0.00%
- 52-week range
- $121.06 – $244.89
- Volume
- 1.03M
- Avg. volume
- 1.61M
Price performance · MOH
MOH price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
MOH closed at $207.85 after 21 trading sessions, up 6.50% for the selected period.
- Last close
- $207.85
- Period change
- +6.50%
- Period low
- $194.82
- Period high
- $219.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $205.27 | $213.29 | $204.49 | $207.85 | 1.03M |
| Nov 2, 2026 | $205.00 | $208.85 | $199.485 | $208.45 | 1.27M |
| Oct 30, 2026 | $201.64 | $206.44 | $198.33 | $204.78 | 1.75M |
| Oct 29, 2026 | $202.34 | $203.40 | $196.435 | $198.95 | 635.68K |
| Oct 28, 2026 | $197.69 | $204.03 | $196.165 | $198.10 | 543.86K |
| Oct 27, 2026 | $201.87 | $205.88 | $196.8701 | $199.46 | 760.58K |
| Oct 26, 2026 | $210.29 | $214.88 | $203.46 | $204.79 | 871.43K |
| Oct 23, 2026 | $213.22 | $220.00 | $206.38 | $209.15 | 1.27M |
| Oct 22, 2026 | $211.68 | $226.00 | $206.70 | $216.64 | 1.82M |
| Oct 21, 2026 | $221.00 | $221.68 | $211.66 | $214.90 | 1.18M |
| Oct 20, 2026 | $212.34 | $221.63 | $211.63 | $219.72 | 1.02M |
| Oct 19, 2026 | $207.37 | $212.62 | $206.44 | $210.20 | 578.26K |
| Oct 16, 2026 | $214.05 | $214.30 | $205.93 | $207.36 | 677.97K |
| Oct 15, 2026 | $210.39 | $214.275 | $208.00 | $212.50 | 771.04K |
| Oct 14, 2026 | $210.15 | $216.93 | $207.58 | $209.19 | 1.23M |
| Oct 13, 2026 | $207.79 | $215.50 | $202.18 | $209.50 | 1.02M |
| Oct 12, 2026 | $197.99 | $207.89 | $196.22 | $204.36 | 697.57K |
| Oct 9, 2026 | $197.69 | $203.67 | $193.32 | $196.93 | 509.22K |
| Oct 8, 2026 | $194.22 | $196.99 | $191.385 | $195.76 | 789.52K |
| Oct 7, 2026 | $194.09 | $198.235 | $192.405 | $194.82 | 899.14K |
| Oct 6, 2026 | $194.66 | $196.79 | $191.58 | $195.17 | 470.9K |
Latest MOH news
The latest Smart Investors Daily articles mentioning MOH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
MOH research
Overview
Company profile and research snapshot.
Company profile
Molina provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in just four states—California, New York, Texas, and Washington—account for over half of its enrollees.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $197.00
- Implied upside
- —
- Analysts
- 27
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 27, 2026 | JP Morgan | Neutral | — |
| Oct 23, 2026 | Morgan Stanley | Equal-Weight | — |
| Oct 23, 2026 | UBS | Neutral | — |
| Oct 23, 2026 | RBC Capital | Sector Perform | — |
| Oct 23, 2026 | Barclays | Underweight | — |
News briefing
No generated briefing is available yet.
Benzinga · Oct 27, 2026
JP Morgan Maintains Neutral on Molina Healthcare, Raises Price Target to $225
JP Morgan analyst John Stansel maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $220 to $225.
Yahoo · Oct 26, 2026
How Much Should This Move Change Your View Of Centene Stock?
For questions about this article or underlying research, email [email protected].
Yahoo · Oct 24, 2026
California Healthcare Stocks Tied To State Funding And Senior Care Demand
California’s proposed wealth tax has turned the state into a live experiment in how aggressive policy can ripple through portfolios, boardrooms, and hospital corridors at the same time. If ultra-rich shareholders adjust where they live and how they invest, capital could shift just as billions of dollars are steered toward state healthcare. This piece unpacks that story and profiles 3 California exposed healthcare stocks most directly in the crosshairs. The three healthcare stocks profiled...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
